Prospective Registration of Taiwan Neonatal Network (TNN)

NCT ID: NCT05294276

Last Updated: 2024-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

26500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-12

Study Completion Date

2050-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Taiwan Neonatal Network (TNN) is an organizational structure that unites the neonatal care centers of multiple hospitals and aims to improve the quality of medical care. Countries around the world have successively established their neonatal medical care network systems to improve the quality of their neonatal care. Since the establishment of the TNN system in 2016, after five years of retrospective statistical analysis of medical records, the establishment of the TNN network system and the short-term and mid-term goals have been completed. In order to continue and improve the long-term goals and objectives of the TNN system, to improve the indicators of newborn care in Taiwan and to establish a more complete preterm infant database, it is planned to change to prospective collection, and the future preterm infant data will be registered in the TNN system. And further establish a database of various preterm infant care outcome indicators and risk factors. After statistical correction, the various preterm infant care outcome indicators among different hospitals can be regarded as the benchmark learning objects of other hospitals, and based on empirical medicine. Medical quality improvement methods have improved the quality of medical care for premature infants in Taiwan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neonatal intensive care medicine has developed very rapidly recently, especially with the help of more advanced technology and novel treatment methods, it has achieved very good results in neonatal medicine. Despite the rapid development of neonatal intensive care medicine, death cannot be avoided with continuously updated medical equipment and treatment methods. This phenomenon is even more pronounced in the medical field of premature infants. In addition, some data can be found in different NICU settings, that is, there will be different significant results. In addition, the cost of neonatal care and medical care is extremely high, and it costs at least 10,000 yuan per day in the NICU. Since the outcome of neonatal care will be affected by the quality of medical care, and the cost of neonatal care is also high, the most important key point in neonatal care is the establishment of novel treatment methods and equipment selection. is effective and highly effective.The Taiwan Neonatal Network System (Taiwan Neonatal Network) is an organizational structure that unites the neonatal care centers of several hospitals and aims to improve the quality of their medical care. Countries around the world have successively established their neonatal medical care network systems to improve the quality of their neonatal care. Taiwan has an average of nearly 200,000 newborns every year, of which 8% to 10% are premature babies, so there are nearly 20,000 premature babies every year. In recent years, its survival rate has been significantly improved. However, premature infants are a high-risk group for complications. Among them, premature infants with a birth weight of less than 1500 grams have a higher mortality and morbidity rate. Therefore, this project is based on Improve the care of premature infants and reduce mortality and sequelae of premature infants.To achieve this goal, the mission is improving the quality and safety of medical care for newborn infants through a multidisciplinary approach of coordinated program of research, education, and quality improvement projects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention related

no intervention related

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Any newborn with a birth weight between 401 grams and 1500 grams or a number of weeks of birth between 22 weeks plus 0 days to 29 weeks plus 6 days of live birth, if one of the above two conditions is met, it meets the preliminary acceptance criteria. Another case meets any of the following conditions:

i. Newborn born in this hospital and admitted to the hospital or ii. Newborn born in this hospital but died in the delivery room (or anywhere in this hospital) before being transferred to the intensive care unit or iii. Newborn born in the outer hospital and transferred to this hospital within 28 days of birth (the newborn has not been discharged and returned home before being transferred from the previous hospital to this hospital).

Exclusion Criteria

Nil
Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taiwan Society of Neonatology

UNKNOWN

Sponsor Role collaborator

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Po-Nien Tsao

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Po-Nien Tsao

Role: CONTACT

02-23123456 ext. 71013

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Po-Nien Tsao, Prof

Role: primary

02-23123456 ext. 71604

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202110099RINA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cohort of Cord Blood Bank
NCT07249099 ENROLLING_BY_INVITATION